Johnson Health Tech Co (TPE:1736) Cyclically Adjusted Revenue per Share: NT$120.43 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1736 Johnson Health Tech Co Ltd TPE:1736
84 GF Score
Price NT$130.50
GF Value NT$157.21
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Johnson Health Tech Co Cyclically Adjusted Revenue per Share?

Johnson Health Tech Co TPE:1736 -2.25% 84 Cyclically Adjusted Revenue per Share is NT$120.43 as of Dec. 2025. GuruFocus rates TPE:1736 with a GF Score™ of 84/100 and a GF Value™ of NT$157.21 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Johnson Health Tech Co's adjusted revenue per share for the three months ended in Dec. 2025 was NT$63.703. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$120.43 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Johnson Health Tech Co's average Cyclically Adjusted Revenue Growth Rate was 12.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Johnson Health Tech Co was 12.20% per year. The lowest was 9.70% per year. And the median was 11.50% per year.

As of today (2026-07-28), Johnson Health Tech Co's current stock price is NT$130.50. Johnson Health Tech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was NT$120.43. Johnson Health Tech Co's Cyclically Adjusted PS Ratio of today is 1.08.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson Health Tech Co was 1.95. The lowest was 0.58. And the median was 1.02.


Johnson Health Tech Co  (TPE:1736) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Johnson Health Tech Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=130.50/120.43
=1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson Health Tech Co was 1.95. The lowest was 0.58. And the median was 1.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Johnson Health Tech Co Cyclically Adjusted Revenue per Share Related Terms


Johnson Health Tech Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Johnson Health Tech Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson Health Tech Co Cyclically Adjusted Revenue per Share Chart

Johnson Health Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.27 86.91 95.93 107.23 120.43

Johnson Health Tech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 107.23 110.62 114.11 116.95 120.43

TPE:1736 vs AS, HAS, LTH: Cyclically Adjusted Revenue per Share Comparison

For the Leisure subindustry, Johnson Health Tech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson Health Tech Co Cyclically Adjusted PS Ratio vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Johnson Health Tech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Johnson Health Tech Co's Cyclically Adjusted PS Ratio falls into.


TPE:1736
84GF Score
Johnson Health Tech Co Ltd TPE:1736
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson Health Tech Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson Health Tech Co's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=63.703/324.0540*324.0540
=63.703

Current CPI (Dec. 2025) = 324.0540.

Johnson Health Tech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 14.517 238.132 19.755
201606 13.618 241.018 18.310
201609 16.963 241.428 22.768
201612 20.886 241.432 28.034
201703 14.646 243.801 19.467
201706 13.311 244.955 17.609
201709 15.653 246.819 20.551
201712 20.983 246.524 27.582
201803 14.797 249.554 19.214
201806 14.855 251.989 19.103
201809 17.857 252.439 22.923
201812 24.241 251.233 31.267
201903 17.612 254.202 22.452
201906 18.501 256.143 23.406
201909 20.231 256.759 25.533
201912 27.124 256.974 34.204
202003 18.265 258.115 22.931
202006 18.585 257.797 23.362
202009 24.688 260.280 30.737
202012 32.212 260.474 40.075
202103 24.024 264.877 29.391
202106 19.157 271.696 22.849
202109 23.758 274.310 28.066
202112 32.192 278.802 37.417
202203 24.874 287.504 28.036
202206 21.769 296.311 23.807
202209 26.622 296.808 29.066
202212 37.954 296.797 41.440
202303 23.225 301.836 24.935
202306 28.500 305.109 30.270
202309 31.944 307.789 33.632
202312 41.998 306.746 44.368
202403 26.496 312.332 27.490
202406 33.878 314.175 34.943
202409 39.934 315.301 41.043
202412 57.193 315.605 58.724
202503 34.980 319.799 35.445
202506 40.681 322.561 40.869
202509 39.596 324.800 39.505
202512 63.703 324.054 63.703

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$120.43 mean?
Johnson Health Tech Co (TPE:1736) has a Cyclically Adjusted Revenue per Share of NT$120.43 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Johnson Health Tech Co and its competitors.
Is Johnson Health Tech Co's Cyclically Adjusted Revenue per Share too high?
Johnson Health Tech Co's current Cyclically Adjusted Revenue per Share is NT$120.43. Overall, Johnson Health Tech Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Johnson Health Tech Co's Cyclically Adjusted Revenue per Share compare to AS and HAS?
Johnson Health Tech Co's Cyclically Adjusted Revenue per Share of NT$120.43 can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Travel & Leisure company?
A good Cyclically Adjusted Revenue per Share depends on the Travel & Leisure industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Johnson Health Tech Co and its competitors. Johnson Health Tech Co's current Cyclically Adjusted Revenue per Share is NT$120.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Health Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Johnson Health Tech Co (TPE:1736) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$157.21, compared to a current price of NT$130.50 — trading 17% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$120.43. Johnson Health Tech Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Johnson Health Tech Co (TPE:1736), the current Cyclically Adjusted Revenue per Share is NT$120.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson Health Tech Co (TPE:1736) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson Health Tech Co stock appears to be undervalued. The current stock price of NT$130.50 is trading 17% below its estimated GF Value™ of NT$157.21. GuruFocus considers Johnson Health Tech Co to be Modestly Undervalued.

Key valuation signals for TPE:1736:

  • Cyclically Adjusted Revenue per Share: NT$120.43
  • GF Value™: NT$157.21 vs. price of NT$130.50 (17% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the TPE:1736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson Health Tech Co Business Description

Address No. 999, Dongda Road, Section 2, Daya District, Taichung, TWN, 428314
Johnson Health Tech Co Ltd is engaged in the manufacturing and selling of sports equipment, cardio equipment, weight training equipment, and related electronic components. It operates in a single industry segment with four strategic segments: American segment: In charge of selling cardiovascular equipment and research and development of training equipment in America; European segment: In charge of selling cardiovascular equipment in Europe; Asian segment: In charge of manufacturing and selling Fuji massage chairs, cardiovascular equipment and weight training equipment in Asia, and franchising the import and export of the above-mentioned products; and Others: In charge of selling cardiovascular machinery in other areas. Geographically, it operates in the Americas, Europe, Asia, and Other.
84GF Score

Get the complete analysis for TPE:1736

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$130.50
Price
NT$157.21
GF Value